Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aelis Farma SA

AELIS.PA ✓ COMPLIANT ☆ Track — members

Euronext Paris · Healthcare · Pharmaceuticals ·

France Micro Cap Analyst: N/A

Last Close

$1.24

▼ -3.60%

Market Cap $16.91M · Vol 69.74K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$16.91M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

62.14

Momentum

Beta

0.57

vs Market

52W High

$2.66

54.97% below

52W Low

$1.10

14.61% above

Volume

69.74K

Avg 14.42K

P/B

3.47

Price-to-book

ROE

-30.78%

Return on equity

Free Float

63.56%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aelis Farma SA (AELIS.PA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AELIS.PA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.69%

+2.10%

-14.94%

-23.02%

YTD

-4.89%

-23.57%

-91.80%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-7,556,699.00
Revenue Growth (YoY)	-100.00%
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	-30.78%
ROA · ROIC	-40.47% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	3.47
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	13.71M

Technical Indicators

50-Day SMA	$1.21
200-Day SMA	$1.39
RSI (14)	62.14
Beta	0.57
52-Week High	$2.66
52-Week Low	$1.10

Volume Today	69.74K
Avg Daily Volume (30D)	14.42K
Relative Volume	4.84x
Volatility (10D)	48.46
Volatility (30D)	42.25
Free Float	63.56%

Analyst Consensus

N/A

Current Price $1.24

Mean Target N/A

52W Low$1.10 52W High$2.66

Current

Target

$1.10 $2.66

Current Analyst target

· 0 analysts

Identifiers

ExchangeEuronext Paris

FIGIBBG01522XM14

ISINFR0014007ZB4

CountryFrance

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Aelis Farma SA is a France-based company that is specialized in the research and development of drugs for the treatment of disorders of Central Nervous System (CNS). The Company provides two products in clinical development, including AEF0117 for cannabis-related disorders (severe dependence, acute psychosis, and acute toxicity), and AEF0217 for cognitive deficits (disorders related to Down syndrome). It offers viable treatments for certain pathological conditions linked to hyperactivity of the CB1 receptor, the main receptor of the endocannabinoid system. It provides advanced drug AEF0117, to combat the harmful effects of cannabis and in particular Cannabis Use Disorders (CUD) which is the current definition of cannabis addiction in the diagnostic manual reference DSM-5. The Company operates a Research and Development (R&D) platform, which enables the Company to discover drug candidates that act as specific modulators of target receptor signaling.